Next Generation of Advanced Non-Small Cell Lung Cancer Therapy: Targeted and Immuno-Therapies
Lung cancer is one of the deadliest cancers in the world. Current clinical trials are focused on developing the next generation of therapies that target novel anti-cancer mechanisms. One approach is to prime the immune system, as the cancer has been known to suppress immune cells in the tumour micro...
Main Authors: | Sze Wah Samuel Chan, Elliot Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
University Library System, University of Pittsburgh
2020-04-01
|
Series: | International Journal of Medical Students |
Subjects: | |
Online Access: | http://ijms.info/IJMS/article/view/446 |
Similar Items
-
Current therapy and development of therapeutic agents for lung cancer
by: Zilai Wang, et al.
Published: (2022-04-01) -
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
by: Lingzhi Hong, et al.
Published: (2022-07-01) -
Clinicopathological Characteristics and Real-life Data of Patients Receiving Tyrosine Kinase Inhibitor in Metastatic EGFR Mutant Non-small Cell Lung Carcinoma
by: Barış EKİNCİ, et al.
Published: (2023-12-01) -
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
by: Ramon Andrade de Mello, et al.
Published: (2020-11-01) -
Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
by: Wenliang Liu, et al.
Published: (2022-11-01)